Form 8-K - Current report:
SEC Accession No. 0001437749-20-023746
Filing Date
2020-11-13
Accepted
2020-11-13 09:30:13
Documents
2
Period of Report
2020-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atos20201111_8k.htm 8-K 34498
2 EXHIBIT 99.1 ex_213626.htm EX-99.1 131327
  Complete submission text file 0001437749-20-023746.txt   167006
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

EIN.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35610 | Film No.: 201309461
SIC: 2834 Pharmaceutical Preparations